CLOs on the Move

Mediture

www.mediture.com

 
Mediture is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mediture.com
  • 7700 Equitable Dr Ste 100
    Eden Prairie, MN USA 55344
  • Phone: 952.400.0300

Executives

Name Title Contact Details

Similar Companies

Boston Brace International

Boston Brace International is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Boston Brace International is based in Avon, MA. You can find more information on Boston Brace International at www.bostonbrace.com

Biodynamics Engineering

Biodynamics Engineering is a Pacific Palisades, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gympass

Gympass partners with companies to offer employees unlimited access to the world`s largest fitness network at 70% off market prices. Spanning 14 countries, we pair our unmatched variety and flexible membership options with consistent, tailored programming that inspires your workforce to enroll, stay motivated, and unlock their full potential. With one membership you access thousands of gyms and studios plus live-stream classes and wellness apps. Our unique approach is designed to propel employee engagement, improve individual performance, and enable business success by revolutionizing corporate wellness.

Rainy Lake Medical Center

Rainy Lake Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in International Falls, MN. To find more information about Rainy Lake Medical Center, please visit www.rainylakemedical.com

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.